Serina Therapeutics, Inc. (SER) Shareholders’ equity 2017–2025
Serina Therapeutics, Inc. (SER) shareholders’ equity at each fiscal year-end, per SEC filings.
-$37,000FY2025 · since FY2017: $7.3M → -$37,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$37,000 | -105.8% |
| FY2024 | $641,000 | +102.0% |
| FY2023 | -$32.3M | +14.5% |
| FY2022 | -$37.8M | -219.3% |
| FY2021 | -$11.8M | -131.3% |
| FY2020 | -$5.1M | -330.7% |
| FY2019 | $2.2M | -70.2% |
| FY2018 | $7.4M | +2.3% |
| FY2017 | $7.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice